Erkki Rintala
Impact in
Papers in
- Surgery 38
- Bladder and Urothelial Cancer Treatments 37
- Urinary and Genital Oncology Studies 32
- Esophageal Cancer Research and Treatment 4
-
- Epigenetics and DNA Methylation 6
- Co-authors
- Per‐Uno Malmström (12 shared papers)Eero Kaasinen (22 shared papers)Pertti Rajala (9 shared papers)Sten Nilsson (4 shared papers)Amir Sherif (4 shared papers)Mika Raitanen (8 shared papers)Harri Juusela (4 shared papers)Eduardo Solsona (2 shared papers)
In The Last Decade
Erkki Rintala
41 papers receiving 2.5k citations
Erkki Rintala's Hit Papers
Peers
Comparison fields: 5 of 77
- Urology 813
- Surgery 2.2k
- Oncology 562
- Pulmonary and Respiratory Medicine 473
- Cancer Research 210
Countries citing papers authored by Erkki Rintala
This map shows the geographic impact of Erkki Rintala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erkki Rintala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erkki Rintala more than expected).
Fields of papers citing papers by Erkki Rintala
This network shows the impact of papers produced by Erkki Rintala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erkki Rintala. The network helps show where Erkki Rintala may publish in the future.
Co-authors
The 25 scholars most cited alongside Erkki Rintala, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C versus Bacillus Calmette-Guérin for Non–Muscle-Invasive Bladder Cancer Hit paper breakdown → | 2009 | 465 |
| 2 | 1999 | 317 | |
| 3 | 2011 | 193 | |
| 4 | 2003 | 180 | |
| 5 | 2002 | 169 | |
| 6 | 1996 | 152 | |
| 7 | 2002 | 127 | |
| 8 | 2002 | 107 | |
| 9 | 2009 | 92 | |
| 10 | 1999 | 80 | |
| 11 | 2005 | 80 | |
| 12 | 2003 | 65 | |
| 13 | 2002 | 64 | |
| 14 | 2002 | 54 | |
| 15 | 1996 | 48 | |
| 16 | 1999 | 44 | |
| 17 | Alternating mitomycin C and bacillus Calmette-Guerin instillation therapy for carcinoma in situ of the bladder. The Finnbladder Group. | 1995 | 38 |
| 18 | 2003 | 37 | |
| 19 | 2000 | 34 | |
| 20 | 1995 | 34 |
About Erkki Rintala
Erkki Rintala is a scholar working on Surgery, Molecular Biology, Urology, Epidemiology and Oncology, having authored 41 papers that have together received 2.6k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (37 papers), Urinary and Genital Oncology Studies (32 papers), Urinary Tract Infections Management (8 papers), Epigenetics and DNA Methylation (6 papers), Urological Disorders and Treatments (6 papers), Cancer Research and Treatments (4 papers), Esophageal Cancer Research and Treatment (4 papers) and Immunotherapy and Immune Responses (3 papers). The work is most often cited by research in Urology (813 citations), Surgery (2.2k citations), Oncology (562 citations), Pulmonary and Respiratory Medicine (473 citations) and Cancer Research (210 citations). Erkki Rintala has collaborated with scholars based in Finland, Sweden and Norway. Frequent co-authors include Per‐Uno Malmström, Eero Kaasinen, Pertti Rajala, Sten Nilsson, Amir Sherif, Mika Raitanen, Harri Juusela, Eduardo Solsona, Teuvo L.J. Tammela and Richard Sylvester. Their work appears in journals such as The Journal of Urology, European Urology, Urology, Molecular Cancer Therapeutics and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.